Girard, N., Aix, S. P., Cedres, S., Berghmans, T., Burgers, S., Toffart, A.-C., Popat, S., Janssens, A., Gervais, R.
, Hochstenbag, M., Silva, M., Burger, I. A., Prosch, H., Stahel, R., Xenophontos, E., Pretzenbaher, Y., Neven, A., & Peters, S. (2023).
Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: results from the EORTC-ETOP NIVOTHYM phase II trial.
ESMO Open,
8(3), Article 101576.
https://doi.org/10.1016/j.esmoop.2023.101576